Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Videos>This Video
  Videos

Return

Vertex Pipette Tips
SSI Robotics

Vertex™ Pipette Tips – Range of low-retention tips developed specifically for life science researchers. SSI, an American manufacturer of consumable plastics for laboratory researchers for over 23 years has launched a new comprehensive family of pipette tips designed to provide researchers with the highest level of liquid handling performance. The Vertex™ Pipette Tips were developed following extensive research to provide users with a high degree of fluid confidence and control while pipetting. SSI internal studies have indicated their tips provide less fluid retention and less sample loss. All Vertex tips are manufactured using SSI’s specially formulated NoStick® resin. Through use of this resin, the inner surface of the tip is considerably more hydrophobic than standard industry tips enabling viscous fluids in particular to be dispensed more completely. The finely tapered tip construction and thinner walls eliminate the need for users to touch off their pipettor. Researchers maintain more pipetting control in general, but especially when working with smaller volumes. SSI has produced a short video detailing their new Vertex™ Pipette Tips. It can be found on their microsite (www.vertextips.com). The new range of tips includes bulk, racked, sterile, and EcoPac® (refill insert) options. They are producing Un-Filtered and Filtered varieties in 10µl, 10µlXL, 200µl, 300µl, 1mL and 1250µl sizes. The Vertex line includes a time-saving EcoPac® Refill System. The new system does not require any tools or special instructions to enable users to move from an empty insert to a fresh set of 96 tips. The Vertex racks were uniquely designed for one-hand operation. A simple press on the front of the lid releases it from the rack; otherwise the lid sits securely closed. The EcoPac refills provide over a 70% savings in total materials (including products and packaging). Since 1990 SSI has been developing and producing innovations for life science at their California home office. They operate under an ISO9001 certified Quality Assurance process and deploy state of the art fully automated manufacturing. SSI disposable products are sold through laboratory supply distributors worldwide.

Request more information
Company product page

Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!